ESMO 2023: Cabozantinib dramatically improved progression-free survival in advanced neuroendocrine tumours
Detailed results from CABINET (A021602), a phase III pivotal trial evaluating cabozantinib compared with placebo…
Browsing: pancreatic neuroendocrine tumours
Study shows pancreatic cancer cells reverse to advance malignancy
A Ludwig Cancer Research study has identified a previously unrecognised mechanism by which cancer cells…
New nuclear medicine method shows promise for better detection of neuroendocrine tumours
Researchers have shown that a new nuclear medicine procedure could safely and more effectively detect…
Australian researchers reveal genetic links underlying neuroendocrine pancreatic cancer
An Australian-led international research effort has revealed that genetic changes normally linked to breast, colon…